CN Stock MarketDetailed Quotes

Jinghua Pharmaceutical Group (002349)

Watchlist
  • 7.47
  • -0.25-3.24%
Market Closed Apr 17 15:00 CST
6.20BMarket Cap27.56P/E (TTM)

Jinghua Pharmaceutical Group (002349) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
4.51%1.09B
1.54%731.42M
-0.98%363.54M
-7.25%1.4B
-6.65%1.05B
-9.43%720.31M
-11.82%367.13M
-3.90%1.51B
-4.71%1.12B
0.48%795.35M
Operating revenue
4.51%1.09B
1.54%731.42M
-0.98%363.54M
-7.25%1.4B
-6.65%1.05B
-9.43%720.31M
-11.82%367.13M
-3.90%1.51B
-4.71%1.12B
0.48%795.35M
Other operating revenue
----
-36.73%7.12M
----
-11.56%13.63M
----
40.25%11.26M
----
-31.75%15.41M
----
-10.72%8.03M
Total operating cost
3.32%853.28M
2.83%558.02M
0.36%279.28M
-6.33%1.11B
-4.51%825.88M
-8.29%542.65M
-6.80%278.29M
-11.10%1.19B
-8.26%864.87M
-4.59%591.68M
Operating cost
-1.31%517.1M
-4.16%339.31M
-3.13%175.13M
-9.03%705.57M
-8.91%523.96M
-12.71%354.04M
-12.46%180.78M
-7.43%775.64M
-5.89%575.2M
-0.78%405.57M
Operating tax surcharges
13.28%17.52M
12.61%11.74M
7.41%5.69M
-2.26%20.82M
-2.18%15.47M
-3.89%10.42M
-7.00%5.3M
-4.83%21.3M
-3.53%15.81M
0.70%10.85M
Operating expense
10.83%203.12M
13.87%132.27M
7.11%62.08M
8.69%247.79M
11.09%183.28M
7.84%116.17M
22.61%57.96M
-9.58%227.97M
-6.55%164.99M
3.89%107.72M
Administration expense
5.79%91.88M
3.10%57.66M
12.17%30.64M
0.11%118.93M
3.56%86.85M
5.86%55.93M
4.14%27.32M
-20.21%118.8M
-20.20%83.86M
-22.10%52.83M
Financial expense
35.54%-19.87M
55.28%-11.81M
53.33%-4.75M
-93.33%-44.75M
-57.77%-30.83M
-87.75%-26.41M
-2,923.92%-10.18M
-53.84%-23.15M
-38.64%-19.54M
-195.05%-14.07M
-Interest expense (Financial expense)
-77.92%456.82K
-68.33%461.85K
-68.46%228.99K
-48.11%1.34M
7.19%2.07M
11.74%1.46M
-11.80%725.9K
-62.12%2.57M
-65.67%1.93M
-67.84%1.31M
-Interest Income (Financial expense)
34.52%-22.05M
51.73%-12.85M
49.19%-5.1M
-86.20%-44.01M
-82.90%-33.68M
-117.09%-26.63M
-212.03%-10.04M
-55.09%-23.64M
-62.63%-18.42M
-99.43%-12.26M
Research and development
-7.66%43.54M
-11.28%28.84M
-38.63%10.5M
-4.38%61.79M
5.85%47.15M
12.95%32.51M
29.47%17.11M
-25.71%64.62M
-6.33%44.54M
-14.96%28.78M
Credit Impairment Loss
74.55%-513.96K
67.68%-829.09K
-22.44%-518.19K
-67.78%-3.4M
-38.78%-2.02M
12.48%-2.57M
81.37%-423.21K
61.23%-2.03M
67.85%-1.46M
39.07%-2.93M
Asset Impairment Loss
-405.39%-4.93M
-226.31%-4.1M
-1,367.95%-3.78M
-91.94%-15.26M
71.41%-974.98K
38.44%-1.26M
120.35%297.88K
65.72%-7.95M
85.43%-3.41M
67.85%-2.04M
Other net revenue
-68.07%3.08M
-89.49%770.12K
-121.25%-1.5M
-27.28%3.13M
326.98%9.65M
692.60%7.32M
455.31%7.06M
-63.17%4.3M
136.64%2.26M
-117.69%-1.24M
Fair value change income
-14.66%3.12M
-57.43%1.45M
-72.71%782.31K
-44.14%3.82M
-28.36%3.66M
21.15%3.41M
216.42%2.87M
36.89%6.83M
26.50%5.11M
-8.36%2.81M
Invest income
-7.24%1.8M
-10.17%1.43M
248.05%472.03K
1,733.65%4.37M
764.74%1.94M
363.31%1.6M
159.51%135.62K
-99.03%238.45K
-112.10%-292.45K
-147.23%-606.28K
-Including: Investment income associates
----
----
----
47.34%-661.26K
-7.54%-661.26K
93.94%-29.08K
186.76%97.06K
---1.26M
---614.89K
---479.8K
Asset deal income
1,133.29%38.9K
799.83%28.38K
--23.91K
-132.38%-202.29K
104.21%3.15K
105.35%3.15K
----
-46.89%-87.05K
-26.46%-74.94K
-17,139.42%-58.91K
Other revenue
-49.43%3.56M
-54.64%2.78M
-63.71%1.52M
89.21%13.8M
194.89%7.04M
286.76%6.14M
309.45%4.18M
-31.81%7.29M
-84.48%2.39M
-88.49%1.59M
Operating profit
5.74%242.08M
-5.84%174.17M
-13.71%82.75M
-10.82%295.06M
-10.94%228.94M
-8.62%184.98M
-17.18%95.9M
31.56%330.85M
13.66%257.05M
13.46%202.43M
Add:Non operating Income
411.99%1.16M
467.62%987.32K
3,627.56%760.23K
194.33%3.2M
-72.00%226.02K
-78.55%173.94K
-95.17%20.39K
-40.38%1.09M
341.48%807.32K
4,411.04%811.1K
Less:Non operating expense
-95.15%191.57K
-98.98%26.87K
-97.74%1.15K
119.91%4.94M
361.02%3.95M
5,233.55%2.63M
18.02%51.11K
-27.42%2.25M
75.82%857.51K
-61.97%49.24K
Total profit
7.92%243.05M
-4.05%175.14M
-12.89%83.51M
-11.03%293.32M
-12.37%225.21M
-10.17%182.53M
-17.48%95.87M
31.77%329.7M
13.79%257M
13.96%203.2M
Less:Income tax cost
-3.47%33.49M
-15.12%23.45M
-13.63%11.99M
-13.86%45.85M
-5.89%34.7M
-6.77%27.62M
-18.95%13.88M
40.36%53.23M
1.07%36.87M
9.70%29.63M
Net profit
10.00%209.55M
-2.08%151.69M
-12.77%71.52M
-10.49%247.47M
-13.46%190.51M
-10.75%154.91M
-17.22%81.98M
30.23%276.47M
16.24%220.13M
14.72%173.56M
Net profit from continuing operation
10.00%209.55M
-2.08%151.69M
-12.77%71.52M
-10.49%247.47M
-13.46%190.51M
-10.75%154.91M
-17.22%81.98M
30.23%276.47M
16.24%220.13M
14.72%173.56M
Less:Minority Profit
26.28%33.18M
8.06%21.04M
-14.72%9.3M
21.01%34.81M
6.03%26.27M
2.71%19.47M
-4.11%10.9M
44,851.53%28.77M
20.88%24.78M
-10.62%18.96M
Net profit of parent company owners
7.39%176.37M
-3.54%130.64M
-12.47%62.22M
-14.15%212.65M
-15.93%164.23M
-12.40%135.43M
-18.92%71.08M
16.71%247.7M
15.68%195.35M
18.85%154.61M
Earning per share
Basic earning per share
6.49%0.2148
-3.49%0.1605
-12.49%0.0764
-14.14%0.2612
-15.92%0.2017
-12.43%0.1663
-18.94%0.0873
16.69%0.3042
15.67%0.2399
18.84%0.1899
Diluted earning per share
6.49%0.2148
-3.49%0.1605
-12.49%0.0764
-14.14%0.2612
-15.92%0.2017
-12.43%0.1663
-18.94%0.0873
16.69%0.3042
15.67%0.2399
18.84%0.1899
Other composite income
-3.22M
Other composite income of parent company owners
----
----
----
----
----
----
----
---3.22M
----
----
Total composite income
10.00%209.55M
-2.08%151.69M
-12.77%71.52M
-9.43%247.47M
-13.46%190.51M
-10.75%154.91M
-17.22%81.98M
28.71%273.24M
16.24%220.13M
14.72%173.56M
Total composite income of parent company owners
7.39%176.37M
-3.54%130.64M
-12.47%62.22M
-13.02%212.65M
-15.93%164.23M
-12.40%135.43M
-18.92%71.08M
15.20%244.47M
15.68%195.35M
18.85%154.61M
Total composite income of minority owners
26.28%33.18M
8.06%21.04M
-14.72%9.3M
21.01%34.81M
6.03%26.27M
2.71%19.47M
-4.11%10.9M
44,851.53%28.77M
20.88%24.78M
-10.62%18.96M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue 4.51%1.09B1.54%731.42M-0.98%363.54M-7.25%1.4B-6.65%1.05B-9.43%720.31M-11.82%367.13M-3.90%1.51B-4.71%1.12B0.48%795.35M
Operating revenue 4.51%1.09B1.54%731.42M-0.98%363.54M-7.25%1.4B-6.65%1.05B-9.43%720.31M-11.82%367.13M-3.90%1.51B-4.71%1.12B0.48%795.35M
Other operating revenue -----36.73%7.12M-----11.56%13.63M----40.25%11.26M-----31.75%15.41M-----10.72%8.03M
Total operating cost 3.32%853.28M2.83%558.02M0.36%279.28M-6.33%1.11B-4.51%825.88M-8.29%542.65M-6.80%278.29M-11.10%1.19B-8.26%864.87M-4.59%591.68M
Operating cost -1.31%517.1M-4.16%339.31M-3.13%175.13M-9.03%705.57M-8.91%523.96M-12.71%354.04M-12.46%180.78M-7.43%775.64M-5.89%575.2M-0.78%405.57M
Operating tax surcharges 13.28%17.52M12.61%11.74M7.41%5.69M-2.26%20.82M-2.18%15.47M-3.89%10.42M-7.00%5.3M-4.83%21.3M-3.53%15.81M0.70%10.85M
Operating expense 10.83%203.12M13.87%132.27M7.11%62.08M8.69%247.79M11.09%183.28M7.84%116.17M22.61%57.96M-9.58%227.97M-6.55%164.99M3.89%107.72M
Administration expense 5.79%91.88M3.10%57.66M12.17%30.64M0.11%118.93M3.56%86.85M5.86%55.93M4.14%27.32M-20.21%118.8M-20.20%83.86M-22.10%52.83M
Financial expense 35.54%-19.87M55.28%-11.81M53.33%-4.75M-93.33%-44.75M-57.77%-30.83M-87.75%-26.41M-2,923.92%-10.18M-53.84%-23.15M-38.64%-19.54M-195.05%-14.07M
-Interest expense (Financial expense) -77.92%456.82K-68.33%461.85K-68.46%228.99K-48.11%1.34M7.19%2.07M11.74%1.46M-11.80%725.9K-62.12%2.57M-65.67%1.93M-67.84%1.31M
-Interest Income (Financial expense) 34.52%-22.05M51.73%-12.85M49.19%-5.1M-86.20%-44.01M-82.90%-33.68M-117.09%-26.63M-212.03%-10.04M-55.09%-23.64M-62.63%-18.42M-99.43%-12.26M
Research and development -7.66%43.54M-11.28%28.84M-38.63%10.5M-4.38%61.79M5.85%47.15M12.95%32.51M29.47%17.11M-25.71%64.62M-6.33%44.54M-14.96%28.78M
Credit Impairment Loss 74.55%-513.96K67.68%-829.09K-22.44%-518.19K-67.78%-3.4M-38.78%-2.02M12.48%-2.57M81.37%-423.21K61.23%-2.03M67.85%-1.46M39.07%-2.93M
Asset Impairment Loss -405.39%-4.93M-226.31%-4.1M-1,367.95%-3.78M-91.94%-15.26M71.41%-974.98K38.44%-1.26M120.35%297.88K65.72%-7.95M85.43%-3.41M67.85%-2.04M
Other net revenue -68.07%3.08M-89.49%770.12K-121.25%-1.5M-27.28%3.13M326.98%9.65M692.60%7.32M455.31%7.06M-63.17%4.3M136.64%2.26M-117.69%-1.24M
Fair value change income -14.66%3.12M-57.43%1.45M-72.71%782.31K-44.14%3.82M-28.36%3.66M21.15%3.41M216.42%2.87M36.89%6.83M26.50%5.11M-8.36%2.81M
Invest income -7.24%1.8M-10.17%1.43M248.05%472.03K1,733.65%4.37M764.74%1.94M363.31%1.6M159.51%135.62K-99.03%238.45K-112.10%-292.45K-147.23%-606.28K
-Including: Investment income associates ------------47.34%-661.26K-7.54%-661.26K93.94%-29.08K186.76%97.06K---1.26M---614.89K---479.8K
Asset deal income 1,133.29%38.9K799.83%28.38K--23.91K-132.38%-202.29K104.21%3.15K105.35%3.15K-----46.89%-87.05K-26.46%-74.94K-17,139.42%-58.91K
Other revenue -49.43%3.56M-54.64%2.78M-63.71%1.52M89.21%13.8M194.89%7.04M286.76%6.14M309.45%4.18M-31.81%7.29M-84.48%2.39M-88.49%1.59M
Operating profit 5.74%242.08M-5.84%174.17M-13.71%82.75M-10.82%295.06M-10.94%228.94M-8.62%184.98M-17.18%95.9M31.56%330.85M13.66%257.05M13.46%202.43M
Add:Non operating Income 411.99%1.16M467.62%987.32K3,627.56%760.23K194.33%3.2M-72.00%226.02K-78.55%173.94K-95.17%20.39K-40.38%1.09M341.48%807.32K4,411.04%811.1K
Less:Non operating expense -95.15%191.57K-98.98%26.87K-97.74%1.15K119.91%4.94M361.02%3.95M5,233.55%2.63M18.02%51.11K-27.42%2.25M75.82%857.51K-61.97%49.24K
Total profit 7.92%243.05M-4.05%175.14M-12.89%83.51M-11.03%293.32M-12.37%225.21M-10.17%182.53M-17.48%95.87M31.77%329.7M13.79%257M13.96%203.2M
Less:Income tax cost -3.47%33.49M-15.12%23.45M-13.63%11.99M-13.86%45.85M-5.89%34.7M-6.77%27.62M-18.95%13.88M40.36%53.23M1.07%36.87M9.70%29.63M
Net profit 10.00%209.55M-2.08%151.69M-12.77%71.52M-10.49%247.47M-13.46%190.51M-10.75%154.91M-17.22%81.98M30.23%276.47M16.24%220.13M14.72%173.56M
Net profit from continuing operation 10.00%209.55M-2.08%151.69M-12.77%71.52M-10.49%247.47M-13.46%190.51M-10.75%154.91M-17.22%81.98M30.23%276.47M16.24%220.13M14.72%173.56M
Less:Minority Profit 26.28%33.18M8.06%21.04M-14.72%9.3M21.01%34.81M6.03%26.27M2.71%19.47M-4.11%10.9M44,851.53%28.77M20.88%24.78M-10.62%18.96M
Net profit of parent company owners 7.39%176.37M-3.54%130.64M-12.47%62.22M-14.15%212.65M-15.93%164.23M-12.40%135.43M-18.92%71.08M16.71%247.7M15.68%195.35M18.85%154.61M
Earning per share
Basic earning per share 6.49%0.2148-3.49%0.1605-12.49%0.0764-14.14%0.2612-15.92%0.2017-12.43%0.1663-18.94%0.087316.69%0.304215.67%0.239918.84%0.1899
Diluted earning per share 6.49%0.2148-3.49%0.1605-12.49%0.0764-14.14%0.2612-15.92%0.2017-12.43%0.1663-18.94%0.087316.69%0.304215.67%0.239918.84%0.1899
Other composite income -3.22M
Other composite income of parent company owners -------------------------------3.22M--------
Total composite income 10.00%209.55M-2.08%151.69M-12.77%71.52M-9.43%247.47M-13.46%190.51M-10.75%154.91M-17.22%81.98M28.71%273.24M16.24%220.13M14.72%173.56M
Total composite income of parent company owners 7.39%176.37M-3.54%130.64M-12.47%62.22M-13.02%212.65M-15.93%164.23M-12.40%135.43M-18.92%71.08M15.20%244.47M15.68%195.35M18.85%154.61M
Total composite income of minority owners 26.28%33.18M8.06%21.04M-14.72%9.3M21.01%34.81M6.03%26.27M2.71%19.47M-4.11%10.9M44,851.53%28.77M20.88%24.78M-10.62%18.96M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Tianheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More